| Literature DB >> 16504059 |
Joshua S Yuan1, Ann Reed, Feng Chen, C Neal Stewart.
Abstract
BACKGROUND: Even though real-time PCR has been broadly applied in biomedical sciences, data processing procedures for the analysis of quantitative real-time PCR are still lacking; specifically in the realm of appropriate statistical treatment. Confidence interval and statistical significance considerations are not explicit in many of the current data analysis approaches. Based on the standard curve method and other useful data analysis methods, we present and compare four statistical approaches and models for the analysis of real-time PCR data.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16504059 PMCID: PMC1395339 DOI: 10.1186/1471-2105-7-85
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Figure 1Real-time PCR. (A) Theoretical plot of PCR cycle number against PCR product amount is depicted. Three phases can be observed for PCRs: exponential phase, linear phase and plateau phase. (B) shows a theoretical plot of PCR cycle number against logarithm PCR product amount. Panel (C) is the output of a serial dilution experiment from an ABI 7000 real-time PCR instrument.
The sample real-time PCR data for analysis. In this data set, there two types of samples (treatment and control); two genes (reference and target); and four concentrations of each combination of gene and sample. For data quality control and ANCOVA analysis, the real-time PCR sample data set can be grouped in four groups according to the combination of sample and gene. The Control-Target combination effect was named group 1, Treatment-Target group 2, Control-Reference group 3 and Treatment-Reference group 4.
| 1 | Control | Target | 10 | 23.1102 | 1 |
| 2 | Control | Target | 10 | 22.9003 | 1 |
| 3 | Control | Target | 10 | 22.8972 | 1 |
| 1 | Control | Target | 2 | 26.5801 | 1 |
| 2 | Control | Target | 2 | 26.2139 | 1 |
| 3 | Control | Target | 2 | 26.0606 | 1 |
| 1 | Control | Target | 0.4 | 28.1125 | 1 |
| 2 | Control | Target | 0.4 | 28.1899 | 1 |
| 3 | Control | Target | 0.4 | 27.5949 | 1 |
| 1 | Control | Target | 0.08 | 30.2772 | 1 |
| 2 | Control | Target | 0.08 | 30.4667 | 1 |
| 3 | Control | Target | 0.08 | 30.7571 | 1 |
| 1 | Treatment | Target | 10 | 21.7813 | 2 |
| 2 | Treatment | Target | 10 | 21.7564 | 2 |
| 3 | Treatment | Target | 10 | 21.641 | 2 |
| 1 | Treatment | Target | 2 | 23.7965 | 2 |
| 2 | Treatment | Target | 2 | 23.7571 | 2 |
| 3 | Treatment | Target | 2 | 23.724 | 2 |
| 1 | Treatment | Target | 0.4 | 26.3794 | 2 |
| 2 | Treatment | Target | 0.4 | 26.2542 | 2 |
| 3 | Treatment | Target | 0.4 | 25.9621 | 2 |
| 1 | Treatment | Target | 0.08 | 28.5479 | 2 |
| 2 | Treatment | Target | 0.08 | 28.3894 | 2 |
| 3 | Treatment | Target | 0.08 | 28.3416 | 2 |
| 1 | Control | Reference | 10 | 19.7415 | 3 |
| 2 | Control | Reference | 10 | 19.494 | 3 |
| 3 | Control | Reference | 10 | 19.3906 | 3 |
| 1 | Control | Reference | 2 | 21.9838 | 3 |
| 2 | Control | Reference | 2 | 22.4435 | 3 |
| 3 | Control | Reference | 2 | 22.57 | 3 |
| 1 | Control | Reference | 0.4 | 24.8109 | 3 |
| 2 | Control | Reference | 0.4 | 24.4327 | 3 |
| 3 | Control | Reference | 0.4 | 24.2342 | 3 |
| 1 | Control | Reference | 0.08 | 26.7319 | 3 |
| 2 | Control | Reference | 0.08 | 26.8206 | 3 |
| 3 | Control | Reference | 0.08 | 26.822 | 3 |
| 1 | Treatment | Reference | 10 | 18.4468 | 4 |
| 2 | Treatment | Reference | 10 | 18.8227 | 4 |
| 3 | Treatment | Reference | 10 | 18.3061 | 4 |
| 1 | Treatment | Reference | 2 | 21.2568 | 4 |
| 2 | Treatment | Reference | 2 | 21.0956 | 4 |
| 3 | Treatment | Reference | 2 | 20.8473 | 4 |
| 1 | Treatment | Reference | 0.4 | 23.2322 | 4 |
| 2 | Treatment | Reference | 0.4 | 22.9577 | 4 |
| 3 | Treatment | Reference | 0.4 | 23.2415 | 4 |
| 1 | Treatment | Reference | 0.08 | 25.4817 | 4 |
| 2 | Treatment | Reference | 0.08 | 25.608 | 4 |
| 3 | Treatment | Reference | 0.08 | 25.5675 | 4 |
Figure 2Data quality control. The four classes represent four different combinations of sample and gene, which are reference gene in control sample, target gene in control sample, reference gene in treatment sample, and target gene in treatment sample. Each class should derive a linear correlation between Ct and logarithm transformed concentration pf PCR product with a slope of -1.
ΔCt calculation. The table presents the calculation of ΔCt, which is derived from subtracting Ct number of reference gene from that of the target gene. Con stands for concentration.
| Control | Target | 10 | 23.1102 | Control | Reference | 10 | 19.7415 | 3.3687 |
| Control | Target | 10 | 22.9003 | Control | Reference | 10 | 19.494 | 3.4063 |
| Control | Target | 10 | 22.8972 | Control | Reference | 10 | 19.3906 | 3.5066 |
| Control | Target | 2 | 26.5801 | Control | Reference | 2 | 21.9838 | 4.5963 |
| Control | Target | 2 | 26.2139 | Control | Reference | 2 | 22.4435 | 3.7704 |
| Control | Target | 2 | 26.0606 | Control | Reference | 2 | 22.57 | 3.4906 |
| Control | Target | 0.4 | 28.1125 | Control | Reference | 0.4 | 24.8109 | 3.3016 |
| Control | Target | 0.4 | 28.1899 | Control | Reference | 0.4 | 24.4327 | 3.7572 |
| Control | Target | 0.4 | 27.5949 | Control | Reference | 0.4 | 24.2342 | 3.3607 |
| Control | Target | 0.08 | 30.2772 | Control | Reference | 0.08 | 26.7319 | 3.5453 |
| Control | Target | 0.08 | 30.4667 | Control | Reference | 0.08 | 26.8206 | 3.6461 |
| Control | Target | 0.08 | 30.7571 | Control | Reference | 0.08 | 26.822 | 3.9351 |
| Treatment | Target | 10 | 21.7813 | Treatment | Reference | 10 | 18.4468 | 3.3345 |
| Treatment | Target | 10 | 21.7564 | Treatment | Reference | 10 | 18.8227 | 2.9337 |
| Treatment | Target | 10 | 21.641 | Treatment | Reference | 10 | 18.3061 | 3.3349 |
| Treatment | Target | 2 | 23.7965 | Treatment | Reference | 2 | 21.2568 | 2.5397 |
| Treatment | Target | 2 | 23.7571 | Treatment | Reference | 2 | 21.0956 | 2.6615 |
| Treatment | Target | 2 | 23.724 | Treatment | Reference | 2 | 20.8473 | 2.8767 |
| Treatment | Target | 0.4 | 26.3794 | Treatment | Reference | 0.4 | 23.2322 | 3.1472 |
| Treatment | Target | 0.4 | 26.2542 | Treatment | Reference | 0.4 | 22.9577 | 3.2965 |
| Treatment | Target | 0.4 | 25.9621 | Treatment | Reference | 0.4 | 23.2415 | 2.7206 |
| Treatment | Target | 0.08 | 28.5479 | Treatment | Reference | 0.08 | 25.4817 | 3.0662 |
| Treatment | Target | 0.08 | 28.3894 | Treatment | Reference | 0.08 | 25.608 | 2.7814 |
| Treatment | Target | 0.08 | 28.3416 | Treatment | Reference | 0.08 | 25.5675 | 2.7741 |
The comparison of four approaches. The table listed ΔΔCt, standard error, P-value and confidence interval derived from the four methods presented in the article. Neither SAS package nor the macro used provides the standard error for Wilcoxon two group test. We consider confidence interval to be sufficient for further data transformation.
| Multiple Regression | -0.6848 | 0.1185 | < 0.0001 | (-0.4435, -0.9262) |
| ANCOVA | -0.6848 | 0.1185 | < 0.0001 | (-0.4435, -0.9262) |
| t-test | -0.6848 | 0.1303 | < 0.0001 | (-0.4147, -0.955) |
| Wilcoxon Test | -0.6354 | < 0.0001 | (-0.4227, -0.8805) |